Ondansetron HCl

CAS No. 99614-01-4

Ondansetron HCl( GR 38032 (hydrochloride) | SN 307 (hydrochloride) )

Catalog No. M19305 CAS No. 99614-01-4

Ondansetron is a serotonin 5-HT3 receptor antagonist, used to prevent nausea and vomiting caused by cancer chemotherapy, and radiation therapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 35 In Stock
50MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ondansetron HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Ondansetron is a serotonin 5-HT3 receptor antagonist, used to prevent nausea and vomiting caused by cancer chemotherapy, and radiation therapy.
  • Description
    Ondansetron is a serotonin 5-HT3 receptor antagonist, used to prevent nausea and vomiting caused by cancer chemotherapy, and radiation therapy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GR 38032 (hydrochloride) | SN 307 (hydrochloride)
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    5-HT3
  • Research Area
    Cancer|Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    99614-01-4
  • Formula Weight
    329.82
  • Molecular Formula
    C18H19N3O·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.CN1C2=CC=CC=C2C2=C1CCC(CN1C=CN=C1C)C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pinelli A, et al. Eur J Pharmacol, 1997, 340(2-3), 111-119.
molnova catalog
related products
  • 7-hydroxycoumarinyl-...

    7-hydroxycoumarinyl-γ-Linolenate is a γ-linolenic acid ester of 7-hydroxycoumarin (umbelliferone) that behaves as a substrate for cPLA2. Hydrolysis of 7-hydroxycoumarinyl-γ-linolenate by phospholipase results in the release of the fluorescent compound 7-hydroxycoumarin which can be monitored spectrophotometrically (excitation at 335 nm, emission at 450 nm).

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • Merepoxine N-oxide

    Merepoxine N-oxide